Lophos Holdings Inc.
Lophos Holdings Inc.
Indice CSE:
Devise:
Lophos Holdings Inc. pertains to the cultivation and research of Lophophora williamsii (“peyote cactus”). Additionally, in the long-term, the Company is engaged in the research and development of compounds derived from peyote cactus. The company’s wholly-owned subsidiary, Lophos Pharmaceuticals Corp., is a biosciences company that specializes in peyote cactus cultivation, research, and sale. It is also licensed to possess, produce, sell/provide, send, transport and deliver the controlled substances covered by its Controlled Substances Dealers License (CSDL), namely mescaline, psilocin and psilocybin.
Lophos Holdings Inc. (MESC)
SEDAR Information
Information d'entreprise
Addresse
620,1111 Melville Street
Vancouver, BC V6E 3V6
CanadaTéléphone
1-833-206-5222Courriel
invest@lophos.comDate d’inscription à la cote
Mercredi, septembre 6, 2023
Agent de transfert
Marrelli Trust Company LimitedCapitalisation
Capitalisation:
85859673Réservé à l'émission:
24197922Communiqués de presse
24/07/2024